Ignazio Fiduccia
Palermo, 90128, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Functionalization of lignocellulosic based fibers for enhanced and sustainable wastewater pollutant removal.
Journal: Physical chemistry chemical physics : PCCP
Published: March 27, 2026
Beyond the stop: Oxadiazole TRIDs restore LRBA protein expression in nonsense-driven primary immunodeficiency.
Journal: Molecular therapy. Nucleic acids
Published: August 12, 2025
Nonsense Mutations in Rare and Ultra-Rare Human Disorders: An Overview.
Journal: IUBMB life
Published: March 31, 2025
A precision medicine approach to primary immunodeficiency disease: Ataluren strikes nonsense mutations once again.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 14, 2024
Promoting readthrough of nonsense mutations in CF mouse model: Biodistribution and efficacy of NV848 in rescuing CFTR protein expression.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 30, 2024
Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene Expression.
Journal: International journal of molecular sciences
Published: August 11, 2023
Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2'-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR.
Journal: International journal of molecular sciences
Published: April 18, 2023
Nonsense codons suppression. An acute toxicity study of three optimized TRIDs in murine model, safety and tolerability evaluation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 08, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026